Gilead Sciences Inc/ US3755581036 /
10/05/2024 16:29:20 | Diferencia - | Volumen | Bid11:54:23 | Ask12:22:21 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
61.03EUR | - | 2 Volumen de negocios: 122.06 |
60.19Volumen de oferta: 75 | 60.56Tamaño/ Volumen/ Formato de Ask: 81 | 75.36 mil millonesEUR | - | - |
GlobeNewswire
12:30
Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Tril...
GlobeNewswire
12:30
Cheer Holding Releases its First AIGC Children’s Animation Super Potato’s Adventure
GlobeNewswire
12:30
Chart Industries to Provide Hydrogen Compression Solutions to Repsol’s Alba Project for its Sines Re...
GlobeNewswire
12:24
Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumou...
GlobeNewswire
12:08
iQIYI, Inc. Announces Repurchase Right Notification for 4.00% Convertible Senior Notes due 2026
GlobeNewswire
12:00
FTAI Aviation Announces Internalization, Terminates Management and Advisory Agreement
GlobeNewswire
12:00
Gran Tierra Energy Inc. Announces Test Results of Arawana-J1 Discovery and Provides Ecuador Explorat...
GlobeNewswire
12:00
Calibre Releases 2023 Sustainability Report, Highlighting Our Commitment to Environmental, Social an...
GlobeNewswire
12:00
Global Warming Solutions Inc. Granted Permit to Revolutionize Hydrogen Production in Kansas
GlobeNewswire
12:00
MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of t...
GlobeNewswire
12:00
Brunswick Corporation to present at 2024 Baird Global Consumer, Technology, & Services Conference
GlobeNewswire
11:54
Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página